Adherium Ltd - Asset Resilience Ratio

Latest as of December 2025: 15.45%

Adherium Ltd (ADR) has an Asset Resilience Ratio of 15.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Adherium Ltd (ADR) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$642.28K
≈ $454.45K USD Cash + Short-term Investments

Total Assets

AU$4.16 Million
≈ $2.94 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2023)

This chart shows how Adherium Ltd's Asset Resilience Ratio has changed over time. See Adherium Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Adherium Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Adherium Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$642.28K 15.45%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$642.28K 15.45%

Asset Resilience Insights

  • Good Liquidity Position: Adherium Ltd maintains a healthy 15.45% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Adherium Ltd Industry Peers by Asset Resilience Ratio

Compare Adherium Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Inspire Medical Systems Inc
NYSE:INSP
Medical Devices 20.29%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Stratec SE
XETRA:SBS
Medical Devices 0.30%
Duearity AB
ST:DEAR
Medical Devices 145.62%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Adherium Ltd (2017–2023)

The table below shows the annual Asset Resilience Ratio data for Adherium Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-06-30 71.58% AU$9.08 Million
≈ $6.42 Million
AU$12.68 Million
≈ $8.97 Million
+9.67pp
2022-06-30 61.91% AU$5.28 Million
≈ $3.74 Million
AU$8.53 Million
≈ $6.04 Million
-26.21pp
2021-06-30 88.13% AU$15.02 Million
≈ $10.62 Million
AU$17.04 Million
≈ $12.06 Million
+19.89pp
2020-06-30 68.23% AU$4.58 Million
≈ $3.24 Million
AU$6.72 Million
≈ $4.75 Million
+34.23pp
2019-06-30 34.00% AU$763.00K
≈ $539.87K
AU$2.24 Million
≈ $1.59 Million
-47.88pp
2018-06-30 81.88% AU$12.54 Million
≈ $8.88 Million
AU$15.32 Million
≈ $10.84 Million
-8.90pp
2017-06-30 90.79% AU$22.78 Million
≈ $16.12 Million
AU$25.09 Million
≈ $17.75 Million
--
pp = percentage points

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$7.60 Million
AU$10.75 Million AUD
Market Cap Rank
#27678 Global
#1408 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more